Data-Driven Decision Making

Acorn Energy partners with AIO Systems to bring AI-driven monitoring to cell towers and data centers, targeting a market projected to exceed $13 billion.

A global RFA leader unveils a new identity, reflecting a strategic shift from pure engineering to a focus on the patient's quality of life.

With key trials in brain and prostate cancer, Curasight heads to a top investor conference to showcase its dual-action theranostic technology.

Abingworth elevates Bali Muralidhar and hires Travis Wilson, signaling a major push into clinical co-development and buyouts under Carlyle's wing.

A major study reveals dropping MMR vaccination rates and a surge in measles, but identifies a key window for pediatricians to prevent missed immunizations.

CDT Equity partners with a top advisory firm to license its drug-enhancing tech, tackling the patent cliff while managing a novel Bitcoin treasury strategy.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.

With recent FDA approval, Belgian MedTech firm Nyxoah prepares for a pivotal presentation of its unique, battery-free sleep apnea implant at JPM.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

XA Investments is launching a new index for credit interval funds, a move set to demystify a booming but opaque market for investors and asset managers.

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.

A chiropractor with millions of followers claims he can reverse dementia. As science eyes a breakthrough, we examine the hope, the hype, and the business.

Medical supply giant Medline closes 2025's largest IPO, raising billions to slash debt and fuel growth, cementing its dominance in the healthcare sector.

A Minnesota startup has secured major funding to advance its bioelectronic device aimed at the brain's waste clearance system for treating CNS disorders.

eXp Realty's new partnership with Land id gives agents advanced mapping tools, promising to reshape property analysis and set new industry standards.

Syra Health appoints Gregory R. Alexander as CEO, banking on his military discipline and record of scaling healthcare firms to drive its next growth phase.

Vanguard Canada projects zero capital gains distributions for three key bond ETFs, offering investors a tax reprieve and a signal on the 2025 market.

As the market for oral supplements explodes, products like Synadentix promise a healthier mouth. But does the science back the billion-dollar marketing?

How ONAR Holding's newly acquired agency, JUICE, used AI to shatter holiday sales records, validating a high-stakes M&A strategy for investors.